JNJ News Alert Johnson & Johnson (JNJ) 104.57 01/01/2015 15:

New Post Public Reply Private Reply Replies (0) Message Board

Jan 1, 2015 at 4:25 PM

Johnson & Johnson (JNJ) 104.57 $JNJ

My K.I.S.S. Dividend Portfolio: 4th Quarter 2014 Update And Year-End Review
The Part-time Investor - at Seeking Alpha - Thu Jan 01, 7:17AM CST

ARLP: 43.05 (+0.24), UTX: 115.00 (-1.20), OKE: 49.79 (-0.17), SYY: 39.69 (-0.57), WMT: 85.88 (-0.91), DEO: 114.09 (-0.28), UGI: 37.98 (-0.90), SPY: 205.54 (-2.06), TGT: 75.91 (+0.20), DE: 88.47 (-0.99), MSFT: 46.45 (-0.57), BBL: 43.00 (-0.37), WPZ: 44.75 (-0.44), HRS: 71.82 (-0.97), HAS: 54.99 (-0.04), NSC: 109.61 (-1.21), COP: 69.06 (-0.87), WFC: 54.82 (-0.60), CSX: 36.23 (-0.20), BA: 129.98 (-1.85), TUP: 63.00 (-0.84), CBRL: 140.76 (+0.29), AVA: 35.35 (-0.98), WPC: 70.10 (-1.55), BPL: 75.66 (-0.99), MCD: 93.70 (-0.55), CVX: 112.18 (-0.93), SDY: 78.80 (-0.91), FLIC: 28.37 (+0.23), NVS: 92.66 (-0.55), 76.90 (-1.40), KMI: 42.31 (-0.19), GD: 137.62 (-2.01), GE: 25.27 (-0.30), BDX: 139.16 (-0.77), LMT: 192.57 (-2.86), MDT: 72.20 (-0.87), DLR: 66.30 (-0.77), RTN: 108.17 (-1.71), PTY: 15.90 (-0.63), O: 47.71 (-1.20), WEC: 52.74 (-0.97), PAA: 51.32 (-0.29), PEP: 94.56 (-1.40), JNJ: 104.57 (-0.79), CINF: 51.83 (-0.61), PAYX: 46.17 (-0.69), NUS: 43.70 (-0.58), QCOM: 74.33 (-0.69), NHI: 69.96 (-1.23), APD: 144.23 (-2.21), EMR: 61.73 (-0.64), SO: 49.11 (-0.66), ITW: 94.70 (-1.37), DRI: 58.63 (-0.16), NLY: 10.81 (-0.17), BIP: 41.87 (+0.19), OHI: 39.07 (-1.22), PG: 91.09 (-1.31), AFL: 61.09 (-0.89), LLL: 126.21 (-1.88)

12 Of The Safest Dividend Aristocrats
Dividend Yield - at Seeking Alpha - Thu Jan 01, 5:18AM CST
Happy New Year! It was a fantastic year 2014 and I hope you've also generated a good performance. I hope that this year can also produce a solid return for my portfolio despite the fact that many analysts are scared about the current market...
SWK: 96.08 (-0.64), MMM: 164.32 (-1.52), JNJ: 104.57 (-0.79), ADP: 83.37 (-0.74), GPC: 106.57 (-1.18), TROW: 85.86 (-1.05), EMR: 61.73 (-0.64), XOM: 92.45 (-0.57), DOV: 71.72 (-1.75), CVX: 112.18 (-0.93), ITW: 94.70 (-1.37), AFL: 61.09 (-0.89)

Retirement: Income Only Or Total Return?
FinancialDave - at Seeking Alpha - Thu Jan 01, 4:19AM CST

JNJ: 104.57 (-0.79), BRK.B: 150.15 (-1.94)

Final Glance: Medical Devices companies
AP - Wed Dec 31, 6:59PM CST
NEW YORK (AP) — Shares of some top medical devices companies were down at the close of trading:
ZMH: 113.42 (-1.15), JNJ: 104.57 (-0.79), MDT: 72.20 (-0.87), BAX: 73.29 (-0.73)

Final Glance: Pharmaceuticals companies
AP - Wed Dec 31, 6:59PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies were down at the close of trading:
JNJ: 104.57 (-0.79), BAX: 73.29 (-0.73), PFE: 31.15 (-0.23), BMY: 59.03 (-0.36)

Idera Gets Orphan Drug Status for its Oncology Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 31, 3:15PM CST
Idera Pharmaceuticals (IDRA) announced that the FDA has granted orphan drug designation to IMO-8400.
JNJ: 104.57 (-0.79), PCYC: 122.26 (-0.32), IDRA: 4.41 (+0.05), AFFX: 9.87 (-0.12)

These 3 Biotechs Are Looking at a Happy New Year
Todd Campbell, The Motley Fool - Motley Fool - Wed Dec 31, 11:33AM CST
This healthcare edition of Industry Focus takes a look at three biotech stocks and why each company is positioned for a great performance in the coming year. If your portfolio could use some exposure to healthcare and biotechs, join the Fool's...
NFLX: 341.61 (-1.62), MDVN: 99.61 (+0.72), JNJ: 104.57 (-0.79), AMZN: 310.35 (+0.05), JPM: 62.58 (-0.57), GILD: 94.26 (-1.02), AGIO: 112.04 (-0.13), AAPL: 110.38 (-2.14), XLRN: 38.96 (+1.30), CELG: 111.86 (-1.68)

How To Profit From Special Dividends
at The Street - Wed Dec 31, 10:47AM CST
By Alex Gavrish, Etalon Investment Research; author of "Wall Street Back To Basics" Sign up for our free daily newsletter Near the end of the year some companies announce special dividends. The pr...
JNJ: 104.57 (-0.79), XOM: 92.45 (-0.57), GM: 34.91 (-0.18), KLAC: 70.32 (-0.87), BA: 129.98 (-1.85)

Early Glance: Pharmaceuticals companies
AP - Wed Dec 31, 9:52AM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 104.57 (-0.79), BAX: 73.29 (-0.73), PFE: 31.15 (-0.23), BMY: 59.03 (-0.36)

Early Glance: Medical Devices companies
AP - Wed Dec 31, 9:52AM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 113.42 (-1.15), JNJ: 104.57 (-0.79), MDT: 72.20 (-0.87), BAX: 73.29 (-0.73)

Johnson & Johnson (JNJ) Approaches New Upside Target of $106.15
Comtex SmarTrend(R) - Wed Dec 31, 8:59AM CST
Shares of Johnson & Johnson (NYSE:JNJ) opened today above their pivot of $105.41 and have already reached the first level of resistance at $105.75. Investors may be interested in a cross of the next upside pivot targets of $106.15 and $106.89.
JNJ: 104.57 (-0.79)

How I Earned 17% Compound Annual Return For 6 Years
Michael Hooper - at Seeking Alpha - Wed Dec 31, 6:51AM CST

RAI: 64.27 (-0.77), JNJ: 104.57 (-0.79), CHD: 78.81 (-0.83), SAM: 289.54 (+0.93), AAPL: 110.38 (-2.14), UNP: 119.13 (-1.12), CL: 69.19 (-0.85)

Portfolio Strategy For Someone Just Starting Out
Financially Free Investor - at Seeking Alpha - Wed Dec 31, 6:30AM CST

KO: 42.22 (-0.54), HCP: 44.03 (-0.66), PDI: 30.74 (+0.39), PCI: 20.65 (+0.20), XOM: 92.45 (-0.57), O: 47.71 (-1.20), DSE: 14.17 (+0.21), KYN: 38.18 (-0.34), T: 33.59 (-0.49), JNJ: 104.57 (-0.79), NMZ: 13.40 (-0.03), RFI: 13.20 (-0.04), UTF: 22.72 (-0.15), PFF: 39.44 (+0.05), PG: 91.09 (-1.31), VZ: 46.78 (-0.55)

Can DGI Aristocrats Beat The Market (Part 2)?
Seng Hong Teoh - at Seeking Alpha - Tue Dec 30, 5:24PM CST

KO: 42.22 (-0.54), MMM: 164.32 (-1.52), JNJ: 104.57 (-0.79), SPY: 205.54 (-2.06), KMB: 115.54 (-1.81), XOM: 92.45 (-0.57), WMT: 85.88 (-0.91), MCD: 93.70 (-0.55), PG: 91.09 (-1.31), CL: 69.19 (-0.85)

Gilead/J&J Expand TAF-based HIV Drugs Related Agreement - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 30, 4:00PM CST
Gilead Sciences, Inc. announced that it has expanded its agreement with Janssen R&D Ireland, a subsidiary of Johnson & Johnson.
AGN: 212.59 (-0.81), JNJ: 104.57 (-0.79), ACT: 257.41 (-2.16), GILD: 94.26 (-1.02)

Midday Glance: Pharmaceuticals companies
AP - Tue Dec 30, 12:24PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 104.57 (-0.79), BAX: 73.29 (-0.73), PFE: 31.15 (-0.23), BMY: 59.03 (-0.36)

Midday Glance: Medical Devices companies
AP - Tue Dec 30, 12:24PM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 113.42 (-1.15), JNJ: 104.57 (-0.79), MDT: 72.20 (-0.87), BAX: 73.29 (-0.73)

3 Biotech Stocks That Soared Past Gilead in 2014 - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Dec 30, 9:41AM CST
Gilead (GILD) has been under pressure due to the pricing of its hepatitis C virus (HCV) treatments.
JNJ: 104.57 (-0.79), ESRX: 84.67 (-1.08), VRTX: 118.80 (-0.35), GILD: 94.26 (-1.02), ACHN: 12.25 (-0.04), ABBV: 65.44 (-0.86)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MLS Org's Sue Compass to Safeguard Fair Listing Access

Real Estate Clash: MLS vs. Compass Imagine flipping on the TV to see a legal showdown brewing in the real estate world — you've got six heavy-hitter MLSs facing off against Compass, Inc. Yeah, we're talking a legal slugfest here, folks, as these MLSs rally to keep the playing field level for over 120,000 agents across the country. They're not messing around, bringing a...

Navigating Legal Advice Post-Car Crash: A Crucial Guide

It's a simple blink-and-you-miss-it moment: one second you're cruising down the street, and the next you're in a fender bender. But if you think you can handle everything solo from here on out, think again. A HelloNation article featuring Pittsburgh attorney Frank Walker brings crucial clarity to when and why you might need a lawyer after a car crash. The Misleading Calm...

JiMMYBAR! Expands Military Retail Footprint Globally

Proteins and Military: A New Rollout Out of the blue, JiMMYBAR! is shaking things up by beefing up their military retail footprint with America's FIRST Creatine + Protein Bar. What's driving this charge? A leap from just promises to actually stocking shelves in 149 military locations worldwide. From home base in the good ol' U.S. of A. to as far-flung as South Korea,...

Genedata's AI Push: A Biotech Game-Changer?

A Glimpse into Genedata's Bold AI Integration So, here's a heck of an ambitious move in the biotech sphere with Genedata dropping the news about their integration of NVIDIA's BioNeMo AI models into their R&D workflows. These folks at Genedata are really riding the tech wave, offering up the new RFD4-Proteina release in what they call 'binder design' for biologics...

Side Bolsters Art Division with Roboto Acquisition

Breaking Into China's Game Art Market The gaming industry's latest buzz centers around Side's acquisition of Roboto Entertainment, a boutique art studio known for crafting immersive game environments. This isn't just another headline grab—this move puts Side smack dab in the heart of China's burgeoning game market with a fresh Chengdu base. Expansion With Strategic...

Ballard Power Eyes Profitability and Growth by 2028

Ballard's Bold Vision for the Future In the sweaty scramble of this hydrogen race, Ballard Power Systems flung their ambition squarely into the ring. Their eyes are set on Adjusted EBITDA profitability by the end of 2027 with a full-year stretch into 2028. It's not just hope they're peddling; they've got a plan, folks! Unpacking the Numbers: Revenue and Strategy...

Union Alarmtronic Joins Forces with Pye-Barker in Key Sale

A Key Merger in Security Sector Here's a deal that's got the market talking: Union Alarmtronic, a stalwart in the security systems arena, has tied the knot with Pye-Barker Fire & Safety, one of the biggest names in fire protection and life safety. This move isn't just another line in the 'mergers & acquisitions' logbook; it's a strategic shift that underscores the growing...

CobbleStone & Chu Chua Tech: A Transformative Alliance

Breaking Down the CobbleStone and Chu Chua Collaboration We’re in a tough, interconnected world where tech innovation is racing against the clock. So, when CobbleStone Software raises its hand to join forces with Chu Chua Technology Services LLP, it’s like a shot of adrenaline for anyone invested in North America’s tech wave. Let’s pause and dive right in because...

D-Wave Quantum Faces Class Action Over Stock Missteps

A lawsuit has been lobbed at D-Wave Quantum Inc., and Wall Street's abuzz over it. Investors who've dabbled in NASDAQ:QBTS between February 26 and August 25, 2026 might be eligible to hop onto this class action lawsuit train. The beef is all about allegedly misleading statements concerning the company's operational outlook, and it's a familiar song and dance when a...

Auburn's Education Fair Bridges Students and Schools

Bridging the Gap: Students Meet Future Employers Walking into Auburn University’s College of Education building, you'd get hit with the buzz of anticipation wafting through the halls. The Fall Education Interview Day was in full swing. With over 35 employers in attendance, this event wasn’t just any run-of-the-mill career fair. This was a chance for students to lock...